Risk factors for the prevalence of nevi: a review

  • Leslie K. Dennis
  • Emily White
Part of the Developments in Oncology book series (DION, volume 73)

Abstract

Melanoma is becoming an important public health problem as incidence rates in many white populations continue to increase. Numerous studies have identified potential risk factors for melanoma [1]. The association of early childhood sun exposures with melanoma supports the importance of ultraviolet exposure in the development of melanoma [2–6]. Nevi, commonly known as moles, may be precursors to melanoma. The evidence for this is based on two types of studies. First, clinical and pathologic evidence suggests that nevi are precursors to melanoma [7]. Patients often report that their melanoma developed at the site of a pre-existing nevus [8,9]. Observation of remnants of dysplastic nevi and other nevi histologically identified in association with melanomas support patient observation [9–13]. Second, epidemiologic studies have shown that the number of nevi is a strong indicator of the risk of developing melanoma [4,14–21]. This finding seems consistent throughout the literature regardless of the method of defining nevi (i.e. by type, size, or location) [22]. Dubin et al. [16] used total body charts for self-assessment of nevus distribution, finding a relative risk of melanoma of 2.0 for 26–100 nevi compared to less than 25 nevi and a relative risk of 3.4 for more than 100 nevi. Swerdlow et al. [21] found relative risks compared to no nevi for melanoma of 4.4 for 10–24 nevi, 8.7 for 25–49 nevi and 63.8 for more than 50 nevi over the whole body. Similarly they found relative risks of 1.7 for 1–9 nevi on the arms and 10.2 for more than 10 nevi on the arms [21]. The association of increasing numbers of nevi with melanoma suggests that nevi are either markers of some exposure that leads to melanoma, potential precursors of melanoma or both [10].

Keywords

Burning Propen Oncol Beach Retinoid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Evans RD, Kopf AW, Lew RA, Rigel DS, Bart RS, Freidman RJ, Rivers JK: Risk factors for the development of malignant melanoma-1: review of case-control studies. J Dermatol Surg Oncol 1988;14:393–408.PubMedGoogle Scholar
  2. 2.
    Elwood JM, Gallagher RP, Hill GB, Spinelli, Pearson JCG, Threlfall W: Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. Br Med J 1984;288:99–102.CrossRefGoogle Scholar
  3. 3.
    Holman CDJ, Armstrong BK, Heenan PJ: A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983;71:651–656.PubMedGoogle Scholar
  4. 4.
    Holman CDJ, Armstrong BK, Heenan PJ, Blackwell JB, Cumming FJ, English DR, Holland S, Kelsall GRH, Matz LR, Rouse IL, Singh A, Ten Seldam REJ, Watt JD, Xu Z: The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 1986;102:18–37.PubMedCrossRefGoogle Scholar
  5. 5.
    Lew RA, Sober AJ, Cook N, Marvell R, Fitzpatrick TB: Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol 1983;8:981–986.Google Scholar
  6. 6.
    Osterlind A, Tucker MA, Stone BJ, Jensen OM: The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 1988;42:319–324.Google Scholar
  7. 7.
    Allen AC. A re-orientation on the histogenesis and clinical significance of cutaneous melanomas and nevi. Cancer 1949;2:28.PubMedCrossRefGoogle Scholar
  8. 8.
    Milton GW. The diagnosis of malignant melanoma. IN: McCarthy WH, ed. Melanoma and Skin Cancer. Sydney: Government Prints, 1973; 163–174.Google Scholar
  9. 9.
    Ariel IM. Theories regarding the cause of malignant melanoma. Surg Gyn Ob 1980; 150:907–917.Google Scholar
  10. 10.
    Elder DE. Human melanocytic neoplasms and their relationship with sunlight. J Invest Dermatol 1989;92:298S–303S.CrossRefGoogle Scholar
  11. 11.
    Rhodes A, Harrist TJ, Day CL et al. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 1983;9:563–574.PubMedCrossRefGoogle Scholar
  12. 12.
    Clark WH, Elder DE, Guerry D, et al. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Human Pathology 1984;15:12:1147–1165.PubMedCrossRefGoogle Scholar
  13. 13.
    Black WC. Residual dysplastic and other nevi in superficial spreading melanoma: clinical correlations and association with sun damage. Cancer 1988;62:163–173.PubMedCrossRefGoogle Scholar
  14. 14.
    Bain C, Colditz GA, Willett WC, Stampfer MJ, Green A Bronstein BR, Mihm MC, Rosner B, Hennekens CH, Speizer FE: Self-reports of mole counts and cutaneous malignant melanoma in women: Methodological Issues and Risk of Disease. Am J Epidemiol 1988;127:703–712.PubMedGoogle Scholar
  15. 15.
    Beral V, Evans S, Shaw H, Milton G: Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 1983;109:165–172.PubMedCrossRefGoogle Scholar
  16. 16.
    Dubin N, Moseson M, Pasternack BS: Epidemiology of malignant melanoma: pigmentary traits, ultraviolet radiation, and the identification of high-risk populations. Recent Results Cancer Res 1986;102:56–75.PubMedCrossRefGoogle Scholar
  17. 17.
    Elwood JM, Williamson C, Stapleton PJ: Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources. Br J Cancer 1986;53:65–74.PubMedCrossRefGoogle Scholar
  18. 18.
    Green A, MacLennan R, Siskind V: Common acquired nevi and risk of malignant melanoma. Int J Cancer 1985;35:297–300.PubMedCrossRefGoogle Scholar
  19. 19.
    Holman CDJ, Armstrong BK: Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984;72:257–266.PubMedGoogle Scholar
  20. 20.
    Roush GC, Nordlund JJ, Forget B, Gruber SB, Kirkwood JM: Independence of dysplastic nevi from total nevi in determining risk for nonfamilial melanoma. Prev Med 1988;17:273–279.PubMedCrossRefGoogle Scholar
  21. 21.
    Swerdlow AJ, English J, MacKie RM, O’Doherty CJ, Hunter JAA, Clark J, Hole DJ: Benign melanocytic nevi as a risk factor for malignant melanoma. Br Med J 1986;292:1555–1559.CrossRefGoogle Scholar
  22. 22.
    Swerdlow AJ, and Green A: Melanocytic nevi and melanoma: an epidemiological perspective. Br J Dermatol 1987;117:137–146.PubMedCrossRefGoogle Scholar
  23. 23.
    Holman CDJ, Armstrong BK, Heenan PJ: Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 1986;76:403–413.PubMedGoogle Scholar
  24. 24.
    Kopf AW, Lazar M, Bart RS, Dubin N, Bromberg J: Prevalence of nevocytic nevi on lateral and medial aspects of arms. J Dermatol Surg Oncol 1978;4:153–158.PubMedGoogle Scholar
  25. 25.
    Augustsson A, Stierner U, Rosdahl I, Suurkula M. Melanocytic nevi in sun-exposed and protected skin in melanoma patients and controls. Acta Derm Venereol (Stockh) 1991;71:512–517.Google Scholar
  26. 26.
    Green A, Siskind V, Hansen MA, Hanson L, Leech P: Melanocytic nevi in schoolchildren in Queensland. J Am Acad Dermatol 1989;20:1054–1060.PubMedCrossRefGoogle Scholar
  27. 27.
    Sigg C, Pelloni F: Frequency of acquired melanonevocytic nevi and their relationship to skin complexion in 939 schoolchildren. Dermatologica 1989;179:123–128.PubMedCrossRefGoogle Scholar
  28. 28.
    Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver KB, Spinelli JJ, Beagrie M: Anatomic distribution of acquired melanocytic nevi in white children. Arch Dermatol 1990; 126:466–471.PubMedCrossRefGoogle Scholar
  29. 29.
    Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver KB, Spinelli JJ, Beagrie M: Suntan, sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Dermatol 1990;126:770–776.PubMedCrossRefGoogle Scholar
  30. 30.
    Sorahan T, Ball PM, Grimley RP, Pope D: Benign pigmented nevi in children from Kidderminster, England: Prevalence and associated factors. J Am Acad Dermatol 1990;22:747–750.PubMedCrossRefGoogle Scholar
  31. 31.
    Coombs BD, Sharpies KJ, Cooke KR, Skegg DCG, Elwood JM. Variation and covariates of the number of benign nevi in adolescents. Am J Epidemiol 1992;136:344–55.PubMedGoogle Scholar
  32. 32.
    Armstrong BK, deKlerk NH, Holman CDJ: Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Natl Cancer Inst 1986;77:329–335.PubMedGoogle Scholar
  33. 33.
    Green A, Bain C, McLennan R, Siskind V: Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res 1986; 102:76–97.PubMedCrossRefGoogle Scholar
  34. 34.
    Schwartzbaum JA, Setzer W, Kupper LL. An exploratory analysis of the occupational correlates of large pigmented nevi at Lawrence Livermore National Laboratory. J Occupat Med 1990;32:7:605–611.CrossRefGoogle Scholar
  35. 35.
    Weinstock MA, Stryker WS, Stampfer MJ, Lew RA, Willett WC, Sober AJ: Sunlight and dysplastic nevus risk. Cancer 1991;67:1701–1706.PubMedCrossRefGoogle Scholar
  36. 36.
    Titus-Ernstoff L, Ernstoff MS, Duray PH, Barnhill RL, Holubkov R, Kirkwood JM: A relation between childhood sun exposure and dysplastic nevus syndrome among patients with nonfamilial melanoma. Epidemiology 1991;2:210–214.PubMedCrossRefGoogle Scholar
  37. 37.
    Magnus K: Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates in Norway 1955–1977 by cohort, sex, age, and primary site. Cancer 1981;48:2329–2335.PubMedCrossRefGoogle Scholar
  38. 38.
    Thorn M, Bergstrom R, Adami H, Ringborg U: Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960–1984. Am J Epidemiol 1990;132:1066–77.PubMedGoogle Scholar
  39. 39.
    Dennis LK, White E, Lee J. Recent cohort trends in malignant melanoma by anatomic site in the United Sates. Cancer Causes Control March 1993, 4:2. In press.Google Scholar
  40. 40.
    Graham S, Marshall J, Haughey B, Stoll H, Zielezny M, Brasure J, West D: An inquiry into the epidemiology of melanoma. Am J Epidemiol 1985;122:606–619.PubMedGoogle Scholar
  41. 41.
    Holman CDJ, Armstrong BK: Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984;73:75–82.PubMedGoogle Scholar
  42. 42.
    Armstrong BK: Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 1988;14:835–849.PubMedGoogle Scholar
  43. 43.
    Kirkpatrick CS. Epidemiology of malignant melanoma and dietary retinoids [dissertation]. Seattle (WA): Univ. of Washington, 1991.Google Scholar
  44. 44.
    Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Bronstein BR, Mihm MC, Speizer FE: Melanoma and the sun: the effect of swimsuits and a “Healthy” tan on the risk of nonfamilial malignant melanoma in women. Am J Epidemiol 1991;134:462–470.PubMedGoogle Scholar
  45. 45.
    Green A, Swerdlow AJ: Epidemiology of melanocytic nevi. Epidemiol Rev 1989;ll:204–221.Google Scholar
  46. 46.
    Longstreth J: Cutaneous malignant melanoma and ultraviolet radiation: a review. Cancer and Metastasis Reviews 1988;7:321–333.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Leslie K. Dennis
  • Emily White

There are no affiliations available

Personalised recommendations